A derogation from the obligation to decommission the unique identifier when medicines are distributed to the United Kingdom will continue to apply for a period of three years

The European Commission has taken decision to extend the transitional period for a period of three years, which was determined in the context of the action of the medicine verification system regarding the medicine products exported to the United Kingdom* (UK) following its’ withdrew from the European Union.